| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 708 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | -708 | -150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | -708 | -150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Primemed Industries Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.680 | 24.428 | 24.015 | 23.574 | 23.118 | 22.679 | 22.176 | 22.245 | 22.178 | 22.054 |
| Current Assets | 19.645 | 19.294 | 18.876 | 18.530 | 18.229 | 17.883 | 17.487 | 17.541 | 17.488 | 17.390 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.397 | 19.199 | 18.875 | 18.528 | 18.169 | 17.825 | 17.430 | 17.484 | 17.431 | 17.333 |
| Cash | 248 | 94 | 2 | 2 | 60 | 59 | 57 | 57 | 57 | 57 |
| Shareholders Funds | -8.874 | -9.491 | -9.481 | -9.307 | -9.127 | -8.954 | -8.755 | -8.782 | -8.755 | -8.707 |
| Social Capital | 6.794 | 6.725 | 6.611 | 6.490 | 6.364 | 6.243 | 6.105 | 6.124 | 6.105 | 6.071 |
| Debts | 53.199 | 53.213 | 52.372 | 51.411 | 50.473 | 49.516 | 48.418 | 48.569 | 48.421 | 48.151 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2120 - 2120" | |||||||||
| CAEN Financial Year |
2120
|
|||||||||
Comments - Primemed Industries Srl